Financial Regulation

The new partnership aims to replace periodic audits with continuous, AI-driven trust, reshaping the GRC landscape for the modern enterprise.

ViruSure's new GMP-validated test using Oxford Nanopore sequencing promises to slash drug safety testing times, boosting supply chain resilience.

Swiss firm Novafjord launches AI-driven arbitrage tools, betting on technology to unlock low-risk returns amid Europe's modest economic recovery.

A new AI platform promises to solve the toxicology industry's capacity crisis, but can it win the trust of regulators and the scientists it’s meant to help?

The data governance firm launches its new 'agentic' platform, aiming to free enterprises from 'pilot purgatory' by unifying data, AI, and compliance.

Early access programs for a rare blindness therapy in France, Israel, and the US offer hope to patients and provide a crucial financial lifeline for the company.

AmMetLife appoints veteran actuary Wan Saifulrizal Wan Ismail as CEO. His deep expertise is set to reshape strategy amid rising health costs and new risks.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

A new anti-cheat system promises fair tables and real value for no-deposit bonuses, but can it solve crypto poker's deep-rooted integrity crisis?

The Texas Association of Builders has updated its industry-standard contracts. Here’s what they mean for risk, affordability, and homeowner protection.

The firm's new ISO 42001 certification signals a major shift towards verifiable, trustworthy AI for the highly regulated life sciences industry.

Crypto exchange Platov.co adds Turkish, Moldovan, and Kazakh currencies, a strategic move into high-demand markets with complex regulatory landscapes.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

The biotech firm accelerates a key trial but faces a partner loss, widening losses, and a CEO search, putting its promising siRNA pipeline at a crossroads.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

Syntax Data launches Saidee, an AI that builds custom portfolios using proprietary, traceable data, aiming to solve key compliance fears for financial advisors.

CrowdStrike and Schwarz Digits partner to deliver AI-native security on a sovereign EU cloud, answering Europe's call for data control amid new regulations.

Amidst industry consolidation, CPAmerica's expansion highlights why independent CPA firms are leveraging associations to gain a competitive edge and global reach.

Backed by Shift4 and Castle Island, Cyclops aims to simplify stablecoin adoption for payment firms with a new, all-in-one platform.

A new growth medium aims to standardize stem cell production, addressing key regulatory and scalability challenges in the booming regenerative medicine market.